Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Surg Pathol ; 48(5): 596-604, 2024 May 01.
Article in English | MEDLINE | ID: mdl-38298024

ABSTRACT

In recent years, the concept of spread through air spaces (STAS) has been discussed as an adverse prognostic factor for lung cancer. The aim of our study is to clarify the prognostic role of STAS in relation to the main recognized prognostic factors in a retrospective cohort of 330 European patients who underwent stages I to III lung adenocarcinoma resection. On univariate analysis, the presence of STAS was related to progression-free survival (PFS; hazard ratio [HR]: 1.48; 95% CI: 1.02-2.19; P = 0.038) and overall survival (OS; HR: 1.61; 95% CI: 1.03-2.52; P = 0.50). On multivariate analysis, STAS was related to PFS (HR: 1.51; 95% CI: 1.00-2.17; P = 0.050) and to OS (HR: 1.67; 95% CI: 1.00-2.81; P = 0.050). We showed that the presence of STAS was associated with lower PFS, equivalent to the next pathologic T stage, especially the median PFS of T3 stages without STAS was at 62.8 months while the median PFS of T3 stages with STAS was at 15.7 months, closer to the median PFS of 17.4 months in T4 stages. To conclude, STAS is an independent prognostic factor of PFS in this European cohort and is close to significance for OS. We suggest that the presence of STAS might lead to an upstaging of lung adenocarcinoma.


Subject(s)
Adenocarcinoma of Lung , Adenocarcinoma , Lung Neoplasms , Humans , Retrospective Studies , Neoplasm Invasiveness/pathology , Adenocarcinoma of Lung/surgery , Adenocarcinoma of Lung/pathology , Lung Neoplasms/pathology , Adenocarcinoma/surgery , Adenocarcinoma/pathology , Prognosis , Neoplasm Recurrence, Local/pathology , Neoplasm Staging
2.
Exp Mol Pathol ; 128: 104836, 2022 10.
Article in English | MEDLINE | ID: mdl-36206956

ABSTRACT

Immunohistochemical demonstration of neuroendocrine differentiation is often performed in routine diagnostic practice for lung neuroendocrine carcinoma. However, these carcinomas are often crushed, especially on small specimens. The value of immunohistochemistry on crushed areas is not known. We aimed to assess the value of immunohistochemical markers in crushed areas. We performed a retrospective study of 299 patients with a diagnosis of pulmonary neuroendocrine carcinoma. We showed that the markers TTF-1, synaptophysin, chromogranin A, CD56, and INSM1 were more often negative in crushed areas compared with well-preserved areas. The proliferation index with anti-Ki67 was decreased but remained on average around 90%. For all markers, the percentage of labeled cells was lower than in the preserved areas. Finally, we show that cases without labeling in the crushed areas and maintained labeling in the non-crushed areas have a lower percentage of labeling than cases without this labeling mismatch. Finally, there were no false positives of these stains. Neuroendocrine markers are valid in crushed areas when positive. However, the percentage of labeled cells may be lower than on preserved areas and lead to false negatives. Finally, the proliferation index, although decreased, remains close to that on preserved areas.


Subject(s)
Carcinoma, Neuroendocrine , Lung Neoplasms , Humans , Immunohistochemistry , Synaptophysin , Chromogranin A , Retrospective Studies , Biomarkers, Tumor , CD56 Antigen , Repressor Proteins , Carcinoma, Neuroendocrine/diagnosis , Carcinoma, Neuroendocrine/pathology , Lung Neoplasms/diagnosis , Lung Neoplasms/pathology , Lung/pathology
SELECTION OF CITATIONS
SEARCH DETAIL